Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol. 2020 05; 77(5):636-643.

View in: PubMed

subject areas

Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Humans
Middle Aged
Neoadjuvant Therapy
Treatment Outcome
Urinary Bladder Neoplasms

authors with profiles

Jonathan Chung